Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Gross Profit
Fusion Antibodies PLC
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Gross Profit
-£117k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Gross Profit
£90.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Gross Profit
£16.7m
|
CAGR 3-Years
18%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Gross Profit
£61.9m
|
CAGR 3-Years
23%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Gross Profit?
Gross Profit
-117k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Gross Profit amounts to -117k GBP.